In terms of experimental validation, future researchers could modify the expression of RSK2 in different breast cancer cell lines and then perform various in vitro and mice xenografts in vivo trials to observe the effects of altering RSK2 expression on the proliferation, apoptosis, cell cycle, metastasis, and invasion capabilities of breast cancer cells. This evidence concerns the gene RPS6KA3 and breast carcinoma.